Navigation Links
Renaissance Health Publishing, LLC Asks Key Credibility Questions of

BOCA RATON, Fla., Dec. 4 /PRNewswire/, LLC claims to be a leading provider of independent test results and information to help consumers and healthcare professionals evaluate health, wellness, and nutrition products. But Renaissance Health Publishing, LLC -- the makers of Revatrol, a red-wine 100MG resveratrol supplement -- is confused and disappointed as to why a recent study by on red wine supplements analyzed a formulation of Revatrol that has been out-of-date for months.

"Not only did they test an obsolete formulation, but Dr. Tod Cooperman of publicly disparaged our product. He insisted our product name implied that it contained resveratrol, but that according to their analysis it contains very little. Dr. Cooperman's statement was an outright misrepresentation," says James DiGeorgia CEO of Renaissance Health Publishing, LLC.

The truth about Revatrol, which would have determined had it exercised adequate due-diligence and tested the current formulation, is that Revatrol contains:
-- 100MG of Actual Resveratrol

-- 100MG Alpha Lipoic Acid

-- 100MG Acetyl-L-Carnitine

-- 100MG Quercetin

According to Renaissance Health, two weeks ago they called on the for- profit laboratory to remove the information currently portrays for Revatrol from its study, and to retest Revatrol's current product, which has been on the market for more than nine (9) months. instead added a notation saying the formulation tested was discontinued.

In the course of Renaissance Health's investigation into this matter and into, they've posed questions that Dr. Tod Cooperman, M.D., president of, LLC, has simply ignored.

"We believe that any organization claiming or implying to be an independent consumer advocate should have no problem answering the basic and simple questions we've asked," says DiGeorgia.

"Our questions go right to the heart of the matter at hand-credibility," explained DiGeorgia. DiGeorgia says the questions that has ignored are:

***Question 1: Is actually a lab or does the company contract outside labs to conduct product testing?

"How can claim to be independent if it accepts fees, accepts advertising and charges $3,000 to $4,000 for laboratory analysis that can be obtained for $400 to $800 from other reputable testing labs?" asks DiGeorgia. "The very name of the implies that this is a lab, yet when we asked whether is actually a laboratory we have gone ignored for many days."

***Question 2: Will please make public all monies received from all companies and persons connected with any and all products they have tested?

"Shouldn't a company that claims independence be willing to voluntarily open its records and reveal what money it's received and from who?" asks DiGeorgia.

***Question 3: Why is a for-profit company instead of a non-for-profit?

" has subscription sales that should be able to support their business model. Why accept any monies from companies that have products which have been or are going to be tested?" wonders DiGeorgia.

"I think it is intellectually dishonest to claim independence, but still accept monies from the companies whose products they test. Moreover, the media has been accepting's testing results without asking these key questions. It's crazy," concludes DiGeorgia.

For more information on Revatrol and its potent anti-aging benefits, please visit or call our knowledgeable representatives at 1-866-482-6678.

SOURCE Renaissance Health Publishing, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Safe storage ... creativity of two inventors, one from Lakewood, New Jersey and the other from Bradley ... the patent-pending PROTECTOR to save the expense of having to replace NuvaRings more often ...
(Date:11/28/2015)... ... ... a.m. EST until 11:59 p.m. EST, customers will be racing the clock ... $80 or more to free gifts with purchases, there will be a new sale available ... for skin care and cosmetic needs, customers will save on already discounted prices. , Top ...
(Date:11/27/2015)... ... ... There is only one major question facing all law firms in the ... has not been an easy question to answer. Especially when the senior partners and ... don’t share the same discipline around working long hours. , In addition to ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... University of Toronto and the University of British Columbia suggested that laws requiring bicyclists ... The article explains that part of the reason for the controversial conclusion is that, ...
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at which ... age, more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions ... overworked. The forgotten part of this equation: 80 percent of medical care occurs ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: